AUS
NZ
UK
CA
USA
IND
Summary
- Moderna Inc (NASDAQ:MRNA) and Cigna Corporation (NYSE:CI) declared quarterly results on Thursday; both the stocks were trading lower.
- Moderna was trading 1.93% down at 9:18 am ET in the pre-market session.
- Cigna was trading 4.09% lower at 8:36 am ET in the pre-market session on Thursday.
The stocks of Moderna Inc. (NASDAQ: MRNA) and Cigna Corporation (NYSE:CI) were trading lower on Thursday after declaring their quarterly results.
MRNA stock was priced at US$410.97, down 1.93%, at 9:18 am ET. CI stock was priced at US$222.01, down 4.09%, at 8:36 am ET in the pre-market session on Thursday.
Moderna Inc’s Q2 performance
Its total revenue for the June quarter was US$4.4 billion compared to US$67 million for the same period a year ago. The covid vaccine sales boosted its Q2 revenue.
Its net income was US$2.8 billion compared to a net loss of US$117 million in the prior year’s June quarter. Its diluted earnings per share were US$6.46.
Also Read: Seven energy stocks to watch as economy nurses back to health
The company’s liquidity reserves increased to US$12.2 billion from US$5.2 billion in the December quarter of 2020. Moderna’s research and development expenses rose to US$421 million from US$152 million a year ago. It expects to deliver 800 million to 1 billion doses of COVID-19 vaccine in FY 2021 and 2 billion to 3 billion doses in FY 2022.
Moderna had 1,800 employees as of June 30, 2021, compared to 930 employees in Q2 2020. The S&P 500 added Moderna to the index on July 21, 2021.
This commercial-stage biotechnology company has a market cap of US$168 billion. The stock gained 453% in one year and closed at US$419.05 on Aug 4, 2021.
Also Read: Top pot stocks to explore as US cannabis market booms
Source: Pixabay
Also Read: Which are the popular industrial stocks to explore in August?
Q2 stats of Cigna Corporation
The health services company earned revenue of US$43.1 billion. Its adjusted revenue also was US$43.1 billion, a 10% growth year-over-year. Its net income was US$1.47 billion, or US$4.25 per share, compared to US$1.75 billion, or US$4.73 per share, for the second quarter of 2020. The adjusted income from operation was US$1.8 billion for the June quarter of 2021.
Cigna’s total customers increased by 6.64 million year-over-year to 191 million. Its pharmacy customers totaled 101,929,000, and medical customers were 16,952,000. Other customers from dental, behavioral care, medicare, etc., were 72,230,000.
Also Read: Fighting back: Four hot media stocks to explore in times of covid
Cigna full-year 2021 guidance for adjusted revenue is expected to be a minimum of US$170 billion. Besides, consolidated adjusted income from operations is expected to be a minimum of US$6.96 billion or US$20.20 per share.
Cigna has a market cap of US$79 billion, a P/E ratio of 9.95, and a dividend yield of 1.71%. CI stock gained 32% in one year. It closed at US$231.48 on Aug 4, 2021.
Please note: The above constitutes a preliminary view and any interest in stocks/cryptocurrencies should be evaluated further from an investment point of view.
